We are live on ! Find out more
Royal Bank of Canada

Royal Bank of Canada Portfolio holdings

AUM $570B
1-Year Est. Return 27.57%
 

Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.

This Fund
S&P 500
This Quarter Est. Return
+1.78%
1 Year Est. Return
+27.57%
3 Year Est. Return
+75.99%
5 Year Est. Return
+94.97%
10 Year Est. Return
+325.25%
AUM
$253B
AUM Growth
+$4.08B
Cap. Flow
+$937M
Cap. Flow %
0.37%
Top 10 Hldgs %
19.37%
Holding
7,530
New
489
Increased
3,007
Reduced
2,579
Closed
641

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$309M
2
ENB icon
Enbridge
ENB
+$233M
3
T icon
AT&T
T
+$219M
4
AGN
Allergan plc
AGN
+$211M
5
MET icon
MetLife
MET
+$202M

Sector Composition

Rank Sector Weight
1 Financials 21.23%
2 Technology 8.83%
3 Energy 8.24%
4 Industrials 7.52%
5 Communication Services 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRGA
5651
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$12K ﹤0.01%
141
-18
-11% -$1.92K
ARD
5652
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
$12K ﹤0.01%
780
+374
+92% +$6.41K
NEOS
5653
DELISTED
Neos Therapeutics, Inc
NEOS
$12K ﹤0.01%
8,100
-4,500
-36% -$7.28K
DPLO
5654
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$12K ﹤0.01%
2,408
-2,374
-50% -$13.3K
VIDG
5655
DELISTED
Defiance Next Gen Video Gaming ETF
VIDG
$12K ﹤0.01%
535
JMT
5656
DELISTED
Nuveen Mortgage Opportunity Term Fund 2
JMT
$12K ﹤0.01%
540
UBNK
5657
DELISTED
United Financial Bancorp, Inc.
UBNK
$12K ﹤0.01%
851
-41
-5% -$554
NTX
5658
DELISTED
Nuveen Texas Quality Municipal Income Fund
NTX
$12K ﹤0.01%
898
LAC
5659
DELISTED
Lithium Americas Corp. Common Shares
LAC
$12K ﹤0.01%
4,017
-46,000
-92% -$164K
ABUS icon
5660
Arbutus Biopharma
ABUS
$912M
$11K ﹤0.01%
7,252
+642
+10% +$1.11K
BCRX icon
5661
BioCryst Pharmaceuticals
BCRX
$2.45B
$11K ﹤0.01%
3,852
+1,699
+79% +$5.29K
CARS icon
5662
Cars.com
CARS
$654M
$11K ﹤0.01%
1,243
-312
-20% -$4.21K
CHT icon
5663
Chunghwa Telecom
CHT
$33B
$11K ﹤0.01%
308
-200
-39% -$7.03K
CVEO icon
5664
Civeo
CVEO
$346M
$11K ﹤0.01%
730
+100
+16% +$1.76K
FBK icon
5665
FB Financial Corp
FBK
$3.09B
$11K ﹤0.01%
280
+10
+4% +$369
FITB
5666
CALL
Fifth Third Bancorp
FITB
$52.8B
$11K ﹤0.01%
400
-1,700
-81% -$46.6K
HOUS
5667
PUT
DELISTED
Anywhere Real Estate
HOUS
$11K ﹤0.01%
1,700
MNSB icon
5668
MainStreet Bancshares
MNSB
$178M
$11K ﹤0.01%
525
-100
-16% -$2.17K
NEWT icon
5669
NewtekOne
NEWT
$375M
$11K ﹤0.01%
+491
New +$10.9K
OVID icon
5670
Ovid Therapeutics
OVID
$517M
$11K ﹤0.01%
3,356
-799
-19% -$1.82K
PGRE
5671
DELISTED
Paramount Group
PGRE
$11K ﹤0.01%
790
-15,445
-95% -$208K
BCIC
5672
BCP Investment Corp
BCIC
$94.1M
$11K ﹤0.01%
483
UDOW icon
5673
ProShares UltraPro Dow 30
UDOW
$923M
$11K ﹤0.01%
404
-4,528
-92% -$117K
VSTM icon
5674
Verastem
VSTM
$589M
$11K ﹤0.01%
758
AAMI
5675
Acadian Asset Management
AAMI
$3.29B
$11K ﹤0.01%
1,044
+802
+331% +$8.15K

Similar funds

Royal Bank of Canada's Q3 2019 Portfolio in Review

As of Q3 2019, Royal Bank of Canada held 7,530 positions worth $253B, up 1.6% from $249B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Royal Bank of Canada's Q3 2019 filing shows 489 new, 3,007 increased, 2,579 reduced and 641 closed positions. Its largest new stake was Genmab: 424,217 shares worth $8.6M. The largest sale was iShares Core S&P 500 ETF, an estimated $983M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 21% a quarter earlier, followed by Technology and Energy.

  • Royal Bank of Canada's largest Q3 2019 buy was Genmab: 424,217 shares worth $8.6M.
  • Royal Bank of Canada added most to Boeing in Q3 2019, an estimated $309M increase.
  • Royal Bank of Canada's biggest Q3 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
  • Royal Bank of Canada fully exited Anadarko Petroleum in Q3 2019, selling an estimated $83.7M.
  • Royal Bank of Canada's ten largest holdings make up 19% of its $253B portfolio in Q3 2019.
  • Royal Bank of Canada opened 489 new positions and closed 641 in Q3 2019.
  • Royal Bank of Canada's portfolio value rose 1.6% quarter-over-quarter to $253B.

Based on Royal Bank of Canada's 13F filing for Q3 2019, filed 14 Nov 2019.